Las Vegas, NV -- (SBWIRE) -- 01/09/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Integrated Device Technology Inc(NASDAQ:IDTI), Select Comfort Corp.(NASDAQ:SCSS), Antares Pharma Inc(NASDAQ:ATRS), KB Home(NYSE:KBH)
Integrated Device Technology Inc(NASDAQ:IDTI) was a volume gainer of 2.72 million shares and the average volume of the stock remained 1.51 million shares. The stock opened the session at $9.79 and finished at the end of the day at $9.92 and the stock escalated 1.74%.The market capitalization of the stock remained 1.50 billion. Integrated Device Technology, Inc. (IDT) designs, develops, manufactures and markets a broad range of low-power mixed signal semiconductor solutions for the advanced communications, computing and consumer industries.
For How Long IDTI will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Select Comfort Corp.(NASDAQ:SCSS) exchanged 2.71 million shares and the average volume remained 1.04 million shares. The stock closed the session at $17.90 with the drop of -0.78%. Select Comfort Corporation (Select Comfort) is a bed manufacturer and retailer. The Company is a manufacturer, marketer, retailer and servicer of the Sleep Number bed, which allows individuals to adjust the firmness and support on each side at the touch of a button.
Why Should Investors Buy SCSS After the Recent Fall? Just Go Here and Find Out
Antares Pharma Inc(NASDAQ:ATRS) enhanced 3.23% and its closing price was $4.80. The volume of the stock was 2.68 million shares and the average volume remained 1.17 million shares. The market capitalization of the stock remained 612.54 million. The beta of the stock remained 0.14. Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. In the gel-based area, it received Food and Drug Administration (FDA) approval in December 2011 for its oxybutynin gel 3% product, Anturol.
Why Should Investors Buy ATRS After The Recent Gain? Just Go Here and Find Out
KB Home(NYSE:KBH) exchanged 2.63 million shares in the previous trading session, and its average trading remained 3.59 million shares. KBH advanced 0.90% and it closed the trading at $17.85. The market capitalization of the stock remained 1.49 billion. KB Home is a builder of single-family residential homes, townhomes and condominiums. It constructs and sells homes homes through its operating divisions under the name KB Home.
For How Long KBH’s Gloss will Attract Investors? Find out via this report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)